FT Pharma Pricing and Value Summit

13 September 2018, New York

Navigating the Market Access Landscape

25% discount for ICON clients

ICON is proud to sponsor the Financial Times Pharma Pricing and Value Summit (New York, September 13th) the theme of which is "Navigating the Market Access Landscape' and will discuss the future of pharmaceutical pricing and market access in an evolving healthcare environment. Topics on agenda include the politics of drug pricing, the rise of real-world evidence, the role of pharmacy benefit managers and what value means to different stakeholders.

ICON will present results and analysis from our original research on ICER’s impact on manufacturer and payer communities.

As a lead sponsor, ICON is pleased to offer clients and other third parties, a 25% discount of the registration fee – a saving of $175 off the full registration price of $695.

Simply complete the short form to receive your discount code.

Request Registration Discount Code

As lead sponsor, ICON is pleased to offer its clients a 25% discount off the Summit's registration costs.

Industry Analysis: Payer and Manufacturer Perspectives on ICER impact

The short and long-term impact of Institute for Clinical and Economic Review (ICER) assessments on payer and manufacturer decision-making surrounding drug pricing, coverage, access, and reimbursement are still not known. ICON will present results and analysis from a 2018 research study of more than 50 payer and manufacturer organisations and their perceptions of ICER’s impact on both the manufacturer and payer communities.

Nathan White, CPC

Senior Vice President, Integrated Access and Outcomes Solutions

For more than 16 years, Mr. White has been offering clients advice on global, US, and European market access and reimbursement challenges. He began his career at Express Scripts, working in leadership, field-based, and internal operational roles in the specialty pharmacy and reimbursement support program divisions. Mr. White spent more than five years designing and implementing reimbursement operational solutions at PAREXEL Consulting and inVentiv Health, before shifting into global access consulting and value communications roles as Director of Market Access at Nucleus Global, Managing Director and Head of Market Access at eMAX Health Systems, and Global Practice Lead at ApotheCom Access Pathways and Outcomes.